Home > News > featured news > ExxonMobil Expands Interest in Biofuels, Acquires Stake in Biojet AS

CHEMICAL MANAGEMENT

ExxonMobil Expands Interest in Biofuels, Acquires Stake in Biojet AS

ExxonMobil | January 12, 2022

ExxonMobil is expanding its interests in biofuels that can help reduce greenhouse gas emissions in the transportation sector, acquiring a 49.9% stake in Biojet AS, a Norwegian biofuels company that plans to convert forestry and wood-based construction waste into lower-emissions biofuels and biofuel components.

Biojet AS plans to develop up to five facilities to produce the biofuels and biofuel components. The company anticipates commercial production to begin in 2025 at a manufacturing plant to be built in Follum, Norway. The agreement enables ExxonMobil to purchase as much as 3 million barrels of the products per year, based on the potential capacity of five facilities.

“The agreement with Biojet AS advances ExxonMobil’s efforts to provide lower-emissions products for the transportation sector. Using our access at the Slagen terminal, we can efficiently distribute biofuels in Norway and to countries throughout northwest Europe.”

 Ian Carr, president of ExxonMobil Fuels and Lubricants Company

Biofuels and biofuel components can meet the requirements for advanced fuels under Norwegian, European Union and United Kingdom regulations. According to the European Union Renewable Energy Directive, biofuels produced from wood waste can help reduce life-cycle greenhouse gas emissions by 85% compared to petroleum-based diesel.

When produced, Biojet AS’s biofuels can be used for passenger vehicles and heavy trucks. Additional opportunities for marine transportation and aviation may develop as the market for lower-emissions biofuels expands.

The investment in Biojet AS builds on ExxonMobil’s continuing efforts to develop and deploy lower-emission energy solutions. ExxonMobil established a Low Carbon Solutions business in 2021 and is currently evaluating biofuels, carbon capture and storage, and hydrogen projects around the world.

ExxonMobil’s majority-owned affiliate, Imperial Oil Ltd., is moving forward with plans to produce renewable diesel at a new complex at its Strathcona refinery, and ExxonMobil expanded its agreement to annually purchase up to 5 million barrels of renewable diesel from Global Clean Energy’s biorefinery in California. Chemically similar to petroleum-based diesel, renewable diesel and other biofuels can be readily blended for use in engines on the market today.

Since 2000, ExxonMobil has invested more than $10 billion to research, develop and deploy lower-emission energy solutions.

About ExxonMobil
ExxonMobil, one of the largest publicly traded international energy companies, uses technology and innovation to help meet the world’s growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is one of the largest refiners and marketers of petroleum products, and its chemical company is one of the largest in the world.

Spotlight

Boost Your Business In Chemical Industry With Sap Commerce Cloud

A B2B E-Commerce platform also provides companies with access to real-time data and insights that can help to inform and guide their business decisions.

More featured news

Spotlight

Boost Your Business In Chemical Industry With Sap Commerce Cloud

A B2B E-Commerce platform also provides companies with access to real-time data and insights that can help to inform and guide their business decisions.

Related News

POLICY AND PERSPECTIVES, COMMODITIES

OQ Chemicals Launches ISCC PLUS Certified OxBalance Isononanoic Acid

OQ Chemicals | March 08, 2023

On March 7, 2023, OQ Chemicals, launched 'OxBalance Isononanoic Acid,' the world's first commercially available isononanoic acid produced from bio-based and circular feedstocks and ISCC PLUS certified. With a bio-based content of over 70%, the new product provides an eco-friendly and sustainable alternative to conventional isononanoic acid. OQ Chemicals has also invested in a capacity expansion project in Germany to meet the increasing demand for carboxylic acids. Isononanoic acid produces various industrial and consumer goods, including energy-efficient lubricants, plasticizers, and surfactants. Dr. Oliver Borgmeier, CEO of OQ Chemicals, stated, "At OQ Chemicals, we are proud to be the first to offer bio-based isononanoic acid. For us, this is the logical next step on our journey towards greater sustainability. We aim to make our large-scale production processes more environmentally friendly, efficient, and sustainable while reducing emissions. As we expand our portfolio of bio-based Oxo Performance Chemicals, such as carboxylic acids, we invest in capacity expansions and explore new ways to innovate and improve our chemical production processes." (Source – Businesswire) OQ Chemicals' OxBalance product line uses the mass balance approach to monitor renewable feedstocks in chemical production processes and distribute them among products. This is done in compliance with the globally recognized sustainability certification system, ISCC PLUS. Also, OxBalance is a trademark owned by OQ Chemicals. About OQ Chemicals OQ Chemicals is a global chemical company that produces and markets high-quality specialty chemicals, including carboxylic acids, esters, and alcohol. The company has a diverse portfolio of products in various industries, such as pharmaceuticals, coatings, adhesives, and electronics. OQ Chemicals was formed in 2020 as a subsidiary of OQ, a globally integrated energy company based in Oman. The chemical company operates production sites and sales offices in Europe, Asia, and the Americas and serves customers in over 100 countries worldwide.

Read More

CHEMICAL MANAGEMENT

Lummus Acquires Water and Wastewater Treatment Technologies from Siemens Energy

PRNewswire | May 29, 2023

Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced that it has reached an agreement with Siemens Energy to acquire assets from their water solutions portfolio including intellectual property and copyrights, trade secrets, and research and development properties. The technologies address water and wastewater needs of the oil and gas industry using carbon adsorption, biological treatment and hydrothermal processes. Lummus will acquire Siemens Energy's Zimpro® wet air oxidation technology and PACT® system, plus the associated intellectual property, lab equipment and associated assets. The technologies will expand Lummus' portfolio of sustainable and integrated offerings into the treatment of water and wastewater produced in petrochemical and refining facilities. "Water and wastewater management in industrial complexes is critical for our customers who are looking for answers to improve energy efficiency, make their operations more sustainable, and comply with environmental regulations and standards," said Leon de Bruyn, President and CEO of Lummus Technology. "This acquisition adds to our growing integrated technology portfolio and provides yet another sustainable solution for our customers." The Zimpro system addresses treatment of caustic waste from ethylene crackers, while the PACT process is an efficient wastewater treatment process designed to remove organic pollutants from industrial wastewater. Both processes offer several advantages over traditional treatment methods, including the conversion and destruction of elevated waste streams, while minimizing the generation of secondary waste streams. The Zimpro and PACT technologies provide solutions for industrial wastewater treatment challenges, yield cleaner wastewater for reuse at industrial facilities and deliver a reliable water resource while reducing risk, carbon footprint and operating costs. About Lummus Technology Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide.

Read More

CHEMICAL MANAGEMENT

Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

Businesswire | May 05, 2023

We are excited to announce a new partnership between Innovassynth and Actylis, two industry-leading companies offering Custom synthesis, Contract manufacturing and off-the-shelf products to the Pharmaceutical and Life Sciences industry. This collaboration will allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials. Innovassynth, India, is a Custom Development & Manufacturing Organization (CDMO) and a trusted partner to Pharma & Drug Discovery, Life Sciences, Diagnostics, and Material Science companies worldwide. They have technological expertise and extensive experience in the field of chemistry, and they provide services from development to commercialization of products. Nucleic acid chemistry is one of Innovassynth’s core competencies, and they have gained a reputation for being a reliable commercial manufacturer of Protected Nucleosides, Phosphoramidites, and Reagents. Their range of Nucleosides includes DNA, RNA, LNA, and GalNAc conjugated derivatives and intermediates with various spacers, linkers, and other building blocks. Innovassynth offers end-to-end manufacturing and a transparent supply chain for Phosphoramidites and a variety of nucleic acid reagents, which is a compelling proposition to customers lacking supply chain diversity. Innovassynth also has significant capability in Process R&D, Custom Synthesis, & Contract Manufacturing of Pharma intermediates, Specialty Chemicals, and Organometallics for customers worldwide. Actylis has a large technical sales team of chemists globally who understand customers’ nucleoside needs and advise on the best solution to their product challenges. Actylis can offer complementary products to the Innovassynth range through its recently acquired GMP manufacturing capabilities in Europe and the US. Actylis provides local and global distribution in the US and Europe through strategically located warehouses, supply chain and sales offices in over ten countries. Actylis can support its customer's development projects through every milestone in the development cycle from R&D to commercial production. "We are truly excited to partner with Actylis which will synergize our reach and offer our customers a wider range of solutions. Due to its techno commercial expertise, global sales and distribution network, Actylis has emerged as the trusted partner of choice. We are committed to providing high-quality products and services to our customers, and we believe this partnership is a step in the right direction,” said Dr. Hardik Joshipura, Managing Director and Chief Executive Officer of Innovassynth. Gilles Cottier, Chief Executive Officer of Actylis, said: “We’ve worked with Innovassynth on several projects over the past couple of years and I’m continually impressed with their capabilities and quality management. They have become a critical outsourcing partner as our internal projects scale. Innovossynth’s backward integrated Phosphoramidite supply chain – all originating in India – from key starters to finished product brings unique value to our customers. Bringing the nucleoside offering to market, together, fills key continuity of supply challenge for our customers and reinforces our position as The Partner of Choice.” About Actylis Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries. We offer standard and custom ingredients through our rapidly growing portfolio of GMP and non-GMP facilities worldwide, and further choice through our strong sourcing hub network. This unique hybrid option blending manufacturing and global sourcing, combined with more than 75 years of sourcing and distribution experience makes Actylis the Partner of Choice.

Read More

POLICY AND PERSPECTIVES, COMMODITIES

OQ Chemicals Launches ISCC PLUS Certified OxBalance Isononanoic Acid

OQ Chemicals | March 08, 2023

On March 7, 2023, OQ Chemicals, launched 'OxBalance Isononanoic Acid,' the world's first commercially available isononanoic acid produced from bio-based and circular feedstocks and ISCC PLUS certified. With a bio-based content of over 70%, the new product provides an eco-friendly and sustainable alternative to conventional isononanoic acid. OQ Chemicals has also invested in a capacity expansion project in Germany to meet the increasing demand for carboxylic acids. Isononanoic acid produces various industrial and consumer goods, including energy-efficient lubricants, plasticizers, and surfactants. Dr. Oliver Borgmeier, CEO of OQ Chemicals, stated, "At OQ Chemicals, we are proud to be the first to offer bio-based isononanoic acid. For us, this is the logical next step on our journey towards greater sustainability. We aim to make our large-scale production processes more environmentally friendly, efficient, and sustainable while reducing emissions. As we expand our portfolio of bio-based Oxo Performance Chemicals, such as carboxylic acids, we invest in capacity expansions and explore new ways to innovate and improve our chemical production processes." (Source – Businesswire) OQ Chemicals' OxBalance product line uses the mass balance approach to monitor renewable feedstocks in chemical production processes and distribute them among products. This is done in compliance with the globally recognized sustainability certification system, ISCC PLUS. Also, OxBalance is a trademark owned by OQ Chemicals. About OQ Chemicals OQ Chemicals is a global chemical company that produces and markets high-quality specialty chemicals, including carboxylic acids, esters, and alcohol. The company has a diverse portfolio of products in various industries, such as pharmaceuticals, coatings, adhesives, and electronics. OQ Chemicals was formed in 2020 as a subsidiary of OQ, a globally integrated energy company based in Oman. The chemical company operates production sites and sales offices in Europe, Asia, and the Americas and serves customers in over 100 countries worldwide.

Read More

CHEMICAL MANAGEMENT

Lummus Acquires Water and Wastewater Treatment Technologies from Siemens Energy

PRNewswire | May 29, 2023

Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced that it has reached an agreement with Siemens Energy to acquire assets from their water solutions portfolio including intellectual property and copyrights, trade secrets, and research and development properties. The technologies address water and wastewater needs of the oil and gas industry using carbon adsorption, biological treatment and hydrothermal processes. Lummus will acquire Siemens Energy's Zimpro® wet air oxidation technology and PACT® system, plus the associated intellectual property, lab equipment and associated assets. The technologies will expand Lummus' portfolio of sustainable and integrated offerings into the treatment of water and wastewater produced in petrochemical and refining facilities. "Water and wastewater management in industrial complexes is critical for our customers who are looking for answers to improve energy efficiency, make their operations more sustainable, and comply with environmental regulations and standards," said Leon de Bruyn, President and CEO of Lummus Technology. "This acquisition adds to our growing integrated technology portfolio and provides yet another sustainable solution for our customers." The Zimpro system addresses treatment of caustic waste from ethylene crackers, while the PACT process is an efficient wastewater treatment process designed to remove organic pollutants from industrial wastewater. Both processes offer several advantages over traditional treatment methods, including the conversion and destruction of elevated waste streams, while minimizing the generation of secondary waste streams. The Zimpro and PACT technologies provide solutions for industrial wastewater treatment challenges, yield cleaner wastewater for reuse at industrial facilities and deliver a reliable water resource while reducing risk, carbon footprint and operating costs. About Lummus Technology Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide.

Read More

CHEMICAL MANAGEMENT

Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

Businesswire | May 05, 2023

We are excited to announce a new partnership between Innovassynth and Actylis, two industry-leading companies offering Custom synthesis, Contract manufacturing and off-the-shelf products to the Pharmaceutical and Life Sciences industry. This collaboration will allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials. Innovassynth, India, is a Custom Development & Manufacturing Organization (CDMO) and a trusted partner to Pharma & Drug Discovery, Life Sciences, Diagnostics, and Material Science companies worldwide. They have technological expertise and extensive experience in the field of chemistry, and they provide services from development to commercialization of products. Nucleic acid chemistry is one of Innovassynth’s core competencies, and they have gained a reputation for being a reliable commercial manufacturer of Protected Nucleosides, Phosphoramidites, and Reagents. Their range of Nucleosides includes DNA, RNA, LNA, and GalNAc conjugated derivatives and intermediates with various spacers, linkers, and other building blocks. Innovassynth offers end-to-end manufacturing and a transparent supply chain for Phosphoramidites and a variety of nucleic acid reagents, which is a compelling proposition to customers lacking supply chain diversity. Innovassynth also has significant capability in Process R&D, Custom Synthesis, & Contract Manufacturing of Pharma intermediates, Specialty Chemicals, and Organometallics for customers worldwide. Actylis has a large technical sales team of chemists globally who understand customers’ nucleoside needs and advise on the best solution to their product challenges. Actylis can offer complementary products to the Innovassynth range through its recently acquired GMP manufacturing capabilities in Europe and the US. Actylis provides local and global distribution in the US and Europe through strategically located warehouses, supply chain and sales offices in over ten countries. Actylis can support its customer's development projects through every milestone in the development cycle from R&D to commercial production. "We are truly excited to partner with Actylis which will synergize our reach and offer our customers a wider range of solutions. Due to its techno commercial expertise, global sales and distribution network, Actylis has emerged as the trusted partner of choice. We are committed to providing high-quality products and services to our customers, and we believe this partnership is a step in the right direction,” said Dr. Hardik Joshipura, Managing Director and Chief Executive Officer of Innovassynth. Gilles Cottier, Chief Executive Officer of Actylis, said: “We’ve worked with Innovassynth on several projects over the past couple of years and I’m continually impressed with their capabilities and quality management. They have become a critical outsourcing partner as our internal projects scale. Innovossynth’s backward integrated Phosphoramidite supply chain – all originating in India – from key starters to finished product brings unique value to our customers. Bringing the nucleoside offering to market, together, fills key continuity of supply challenge for our customers and reinforces our position as The Partner of Choice.” About Actylis Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries. We offer standard and custom ingredients through our rapidly growing portfolio of GMP and non-GMP facilities worldwide, and further choice through our strong sourcing hub network. This unique hybrid option blending manufacturing and global sourcing, combined with more than 75 years of sourcing and distribution experience makes Actylis the Partner of Choice.

Read More

More featured news